Category Archives: Cancer

Cancer Treatment Centers of America joins hands with the NFL Alumni Association and LabCorp to provide Prostate cancer screening services

Prostate cancer is arguably one of the most common types of cancer among men. Cancer Treatment Centers of America (CTCA) in partnership with the National Football League Alumni Association (NFLA) and LabCorp have launched a bid to create massive awareness of Prostate cancer and the reason for early screening. From September 1st to 15th October, some 2000 men who are 40 years old and above will receive free Prostate cancer screening at any of Labcorp’s 1,750 outlets countrywide.

One in seven American men is likely to be diagnosed prostate cancer. The American Cancer Society predicts over 161,000 new prostate cancer diagnoses next year. Men who are past age 40 are at a higher risk. The same applies to African-American men.

The Prostate Pep Talk campaign has seen decorated former NFL head coaches Herm Edwards, and Bill Cowher participate in public service announcements. The announcements, which will air countrywide throughout September, will create awareness of risk prostate cancer poses and benefits of early screening. A press conference which will feature former defensive back Beasley Reece who is a five-time Emmy award winner.

Other former NFL players including Mike Quick and Jon Runyan. Some of the players and coaches have seen family members or friends battle with prostate cancer. Sean Cavanaugh who is head of Radiation Oncology at CTCA Southeastern branch, Gary Huff who is CEO LabCorp and Carl Baylor who is a stage IV prostate cancer survivor all will be in attendance.

Cancer Treatment Centers of America is a company with its headquarters in Boca Raton, Florida. It comprises of five hospitals that specialize in cancer treatment. The five hospitals, in Atlanta, Chicago, Tulsa, Phoenix, and Philadelphia serve all US citizens.

CTCA offers a unique treatment approach that encompasses surgery, immunotherapy, chemotherapy, and radiation to treat cancer and manage side effects as well. The treatment plan is patient-centered and unique to every patient.

Read More : http://www.myctca.com

Eric Lefkofsky Is Doing Great Things

Cancer is one of the hardest-hitting diseases in our modern society. Even though doctors haven’t conquered cancer thus far, it’s reasonable to say that in the future, the medical community will have mitigated the prevalence and lethality of cancer, just as modern medicine has all but eliminated the chances of dying or being permanently disabled from polio, smallpox, strep throat, and related illnesses that are nothing more than minor problems in today’s world.

A survey conducted by physicians and researchers from the Department of Clinical Sciences at the University of Texas, the Dallas-based Comprehensive Cancer Center, and the Department of Internal Medicine at the same university has indicated the general likelihood of people who have already been diagnosed with cancer once before and beat the disease involuntarily succumbing to such a diagnosis again.

The meta-analysis conducted found that, of roughly 741,000 individuals recently diagnosed with cancer, about 25 percent of people older than 64 years of age had experienced cancer before, whereas only 11 percent of individuals younger than 65 years of age experienced the same condition.

Further, depending on the particular type of cancer patients had experienced in the past, the prevalence of past cancer rates ranged from only 4 percent, all the way up to 37 percent, for more pervasive strains, and areas of the body affected that are generally harder to cure.

The aforementioned study was conducted across the Surveillance, Epidemiology, and End Results program – often called the SEER program – and contained sources of cancer related information in clinical settings from such registries dating from as far back as 1975, to as recently as 2013.

Arguably the most positive finding of the study is that survival rates are improving, and physicians are collectively learning more about the treatment of the disease.

Eric Lefkofsky is a Co-founder of Tempus, a technological organization that is currently building a digital library of information directly related to molecular biological data, as well as clinical performance information.

Mr. Lefkossky began his career at the University of Michigan, earning both a bachelor’s and juris doctorate at the school. His entrepreneurial spirit originally led him to sell carpet during school. After graduation, he founded an apparel company  the rest is history.

Visit More Click Here